The news is directly related to Baxter Intl as Barclays has maintained an Overweight rating but lowered the price target. This could lead to mixed reactions in the market, with some investors seeing the lowered price target as a negative signal, while others may still see potential due to the maintained Overweight rating. Therefore, the short-term impact on the stock price is neutral.